Literature DB >> 11796744

P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress.

Robert A Felix1, Margery A Barrand.   

Abstract

During ischaemia/reperfusion, cells of the blood-brain barrier are subjected to oxidative stress. This study uses primary cultured rat brain endothelial cells to examine the effect of such stresses on expression of multidrug transporters. H(2)O(2) up to 500 microm applied to cell monolayers caused a concentration-dependent increase in expression of P-glycoprotein (Pgp) but not of multidrug resistance-associated protein (Mrp1). Concentrations > 250 microm H(2)O(2) decreased cell viability. Application of 100 microm H(2)O(2) caused a significant increase after 48 h in Pgp functional activity, as assessed from [(3)H]vincristine accumulation experiments. At this concentration, H(2)O(2) produced a transient increase within 10 min followed by a sustained decrease in levels of intracellular reactive oxygen species (iROS), detectable by flow cytometry. Reoxygenation of cell monolayers after 6 h hypoxia gave rise to a similar transient increase in iROS and this also led to increased Pgp expression by 24 h. Increases were also observed within 4 h after both H(2)O(2) and hypoxia/reoxygenation treatments in mdr1a and mdr1b mRNA. Evidence suggests this was due to enhanced transcription rather than mRNA stabilization. Therefore, oxidative stress, by changing Pgp expression, may affect movement of Pgp substrates in and out of the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796744     DOI: 10.1046/j.0022-3042.2001.00660.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

1.  Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier.

Authors:  Dirk M Hermann
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

2.  Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood-brain barrier.

Authors:  Yutaro Hoshi; Yasuo Uchida; Masanori Tachikawa; Sumio Ohtsuki; Pierre-Olivier Couraud; Takashi Suzuki; Tetsuya Terasaki
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-09       Impact factor: 6.200

Review 3.  Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Authors:  David S Miller; Björn Bauer; Anika M S Hartz
Journal:  Pharmacol Rev       Date:  2008-06-17       Impact factor: 25.468

4.  Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis.

Authors:  Loqman A Mohamed; Shashirekha S Markandaiah; Silvia Bonanno; Piera Pasinelli; Davide Trotti
Journal:  Exp Neurol       Date:  2019-04-09       Impact factor: 5.330

5.  Nitric oxide contributes to hypoxia-reoxygenation-induced P-glycoprotein expression in rat brain endothelial cells.

Authors:  Samantha J Robertson; Ruth Mokgokong; Katarzyna D Kania; Anne-Sophie Guedj; Stephen B Hladky; Margery A Barrand
Journal:  Cell Mol Neurobiol       Date:  2011-05-27       Impact factor: 5.046

Review 6.  Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.

Authors:  Hisham Qosa; David S Miller; Piera Pasinelli; Davide Trotti
Journal:  Brain Res       Date:  2015-07-15       Impact factor: 3.252

Review 7.  Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

Authors:  David S Miller
Journal:  Trends Pharmacol Sci       Date:  2010-04-24       Impact factor: 14.819

8.  Reduction of brain infarction induced by a transient brain ischemia in mdr1a knockout mice.

Authors:  Michihiro Murozono; Shohei Matsumoto; Shinya Okada; Daisuke Nagaoka; Atsushi Isshiki; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2009-03-10       Impact factor: 3.996

9.  Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.

Authors:  Xueqian Wang; Christopher R Campos; John C Peart; Lindsay K Smith; Jessica L Boni; Ronald E Cannon; David S Miller
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

Review 10.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.